Protein-protein interaction inhibitors: advances in anticancer drug design.
about
Altered Protein Interactions of the Endogenous Interactome of PTPIP51 towards MAPK Signaling.Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation.Regioselective synthesis, biological evaluation, and molecular docking of dihydropyrimidin-4-ols as acetylcholinesterase inhibitors.Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity.
P2860
Protein-protein interaction inhibitors: advances in anticancer drug design.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Protein-protein interaction inhibitors: advances in anticancer drug design.
@en
type
label
Protein-protein interaction inhibitors: advances in anticancer drug design.
@en
prefLabel
Protein-protein interaction inhibitors: advances in anticancer drug design.
@en
P2860
P1476
Protein-protein interaction inhibitors: advances in anticancer drug design
@en
P2093
Adriano D Andricopulo
Glaucius Oliva
P2860
P304
P356
10.1080/17460441.2016.1223038
P407
P577
2016-09-02T00:00:00Z